Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

about

Never-in-mitosis A-related kinase 8, a novel target of von-Hippel-Lindau tumor suppressor protein, promotes gastric cancer cell proliferation Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer

P2860

Q58573422-A5B30A24-E32A-4843-9D4A-DAABC3FD5509 Q58584387-6605824F-0198-4597-AE10-F51C8E5EADB8

P2860

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

Item

http://www.wikidata.org/entity/Q55117181

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

@en

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

@nl

type

Item

label

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

@en

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

@nl

prefLabel

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

@en

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

@nl

P1476

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology

@en

P2093

George Johan Arnold Offerhaus

http://www.w3.org/2001/XMLSchema#string

Karol Rawicz-Pruszyński

http://www.w3.org/2001/XMLSchema#string

Magdalena Cisło

http://www.w3.org/2001/XMLSchema#string

Wojciech Piotr Polkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Mucins in cancer: function, prognosis and therapy

Molecular alterations in gastric cancer with special reference to the early-onset subtype

Diagnosis and management of gastric dysplasia

Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application

Translating gastric cancer genomics into targeted therapies

Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification

P304

19427-19442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24827

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Agata A Filip

Bogumiła Ciseł

Małgorzata Skierucha

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29721214

http://www.w3.org/2001/XMLSchema#string

P932

5922408

http://www.w3.org/2001/XMLSchema#string

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

about

P2860

P2860

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932